This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Ashland (ASH) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Ashland (ASH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes Ashland (ASH) a New Strong Buy Stock
by Zacks Equity Research
Ashland (ASH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks For July 22nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Ashland (ASH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Issues Updates for Preliminary Q3 Results
by Zacks Equity Research
Ashland's (ASH) financial results in the third quarter showcase the strength of its specialty materials portfolio.
Chemical Specialty Industry Outlook Bleak on Muted Demand
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus pose as headwinds to the chemical specialty industry.
ASH or LTHM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ASH vs. LTHM: Which Stock Is the Better Value Option?
Ashland's (ASH) Q2 Earnings In Line, Revenues Beat Estimates
by Zacks Equity Research
Ashland's (ASH) Q2 revenues were hurt by business losses in oral care and the legacy Pharmachem business.
Ashland (ASH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coronavirus, Tariffs Mar Chemical Specialty Industry Outlook
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus as well as hefty trade tariffs pose as headwinds to the chemical specialty industry.
Ashland (ASH) Earnings Beat Estimates in Q1, Sales Miss
by Zacks Equity Research
Ashland (ASH) faces challenges from softer industrial and consumer end-market demand in Q1.
Ashland (ASH) Beats Q1 Earnings Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 30.00% and -0.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Declares Completion of Senior Notes Offering
by Zacks Equity Research
The notes were guaranteed initially by Ashland (ASH) and its fully-owned subsidiary, Ashland LLC.
Earnings Preview: Ashland (ASH) Q1 Earnings Expected to Decline
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WLKP vs. ASH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
WLKP vs. ASH: Which Stock Is the Better Value Option?
Ashland Declares Pricing of Senior Notes Offering Due 2028
by Zacks Equity Research
Initially, the notes will be guaranteed by each of Ashland (ASH) and its fully-owned subsidiary, Ashland LLC on an unsecured basis.
Ashland's (ASH) Subsidiary Announces Senior Notes Offering
by Zacks Equity Research
The notes will be guaranteed initially by Ashland (ASH) and its fully-owned subsidiary, Ashland LLC.
Ashland (ASH) to Realign Business Operations Starting 2020
by Zacks Equity Research
Ashland (ASH) plans to implement core changes, resource management, leadership teams, processes and financial reporting during the second quarter of fiscal 2020.
New Strong Sell Stocks for December 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Ashland Launches Two New Hydrophobic Polymers-Based Defoamers
by Zacks Equity Research
Ashland's (ASH) new defoamers have an overall improved cost efficiency.
Ashland (ASH) Earnings & Sales Fall Short of Estimates in Q4
by Zacks Equity Research
Ashland (ASH) faced challenges from softer industrial end-market demand and weak results at Pharmachem and Personal Care businesses in Q4.
Ashland (ASH) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -21.43% and -5.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Q3 Earnings Meet Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 0.00% and 0.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?